Skip to content
European Medicines Agency initiates review process for Sputnik V – RT in French

The Russian vaccine against Covid-19 is now under review by the European Medicines Agency (EMA). The procedure, launched on March 4, could lead to the provision of Sputnik V in European countries.

On March 4, the Russian Direct Investment Fund (RDIF) – the source of funding for Sputnik V – announced in a statement that the European Medicines Agency (EMA) had started the review process for the Russian vaccine. against Covid-19.

Details to follow …



Source link